Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables.
Acta Neuropathol Commun. 2018 Dec 5;6(1):135. doi: 10.1186/s40478-018-0621-2.
Acta Neuropathol Commun. 2018.
PMID: 30518425
Free PMC article.
Clinical Trial.
Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production.
Erhart F, Weiss T, Klingenbrunner S, Fischhuber K, Reitermaier R, Halfmann A, Blauensteiner B, Lötsch D, Spiegl-Kreinecker S, Berger W, Sialana FJ, Lubec G, Felzmann T, Dohnal A, Visus C.
Erhart F, et al. Among authors: klingenbrunner s.
Cytotherapy. 2019 Jun;21(6):643-658. doi: 10.1016/j.jcyt.2019.03.002. Epub 2019 Apr 8.
Cytotherapy. 2019.
PMID: 30975602
Item in Clipboard
Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature.
Erhart F, Blauensteiner B, Zirkovits G, Printz D, Soukup K, Klingenbrunner S, Fischhuber K, Reitermaier R, Halfmann A, Lötsch D, Spiegl-Kreinecker S, Berger W, Visus C, Dohnal A.
Erhart F, et al. Among authors: klingenbrunner s.
J Cell Mol Med. 2019 Jan;23(1):281-292. doi: 10.1111/jcmm.13927. Epub 2018 Nov 22.
J Cell Mol Med. 2019.
PMID: 30467961
Free PMC article.
Item in Clipboard
Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors.
Erhart F, Hackl M, Hahne H, Buchroithner J, Meng C, Klingenbrunner S, Reitermaier R, Fischhuber K, Skalicky S, Berger W, Spiegl-Kreinecker S, Lötsch D, Ricken G, Kuster B, Wöhrer A, Widhalm G, Hainfellner J, Felzmann T, Dohnal AM, Marosi C, Visus C.
Erhart F, et al. Among authors: klingenbrunner s.
NPJ Vaccines. 2020 Jan 16;5(1):5. doi: 10.1038/s41541-019-0149-x. eCollection 2020.
NPJ Vaccines. 2020.
PMID: 31969991
Free PMC article.
Item in Clipboard
Item in Clipboard
EVI1 promotes tumor growth via transcriptional repression of MS4A3.
Heller G, Rommer A, Steinleitner K, Etzler J, Hackl H, Heffeter P, Tomasich E, Filipits M, Steinmetz B, Topakian T, Klingenbrunner S, Ziegler B, Spittler A, Zöchbauer-Müller S, Berger W, Wieser R.
Heller G, et al. Among authors: klingenbrunner s.
J Hematol Oncol. 2015 Mar 21;8:28. doi: 10.1186/s13045-015-0124-6.
J Hematol Oncol. 2015.
PMID: 25886616
Free PMC article.
Item in Clipboard
NF-κB addiction and resistance to 5-fluorouracil in a multi-stage colon carcinoma model.
Körber MI, Klingenbrunner S, Bartsch R, Steger GG, Mader RM.
Körber MI, et al. Among authors: klingenbrunner s.
Int J Clin Pharmacol Ther. 2013 Jan;51(1):35-7. doi: 10.5414/cpp51035.
Int J Clin Pharmacol Ther. 2013.
PMID: 23259994
Free article.
No abstract available.
Item in Clipboard
Cite
Cite